Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics

Oral Diseases

Volumn 16, Issue 5, 2010, Pages 476-481

  Kardesler L ^a   Biyikolu, B ^a   Cetinkalp S ^a   Pitkala, M ^b   Sorsa, T ^b   Buduneli, N ^a  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Diabetes mellitus; ELISA; Gingival crevicular fluid; IFMA; MMP 13; MMP 8; Periodontal disease; TIMP 1

Indexed keywords

COLLAGENASE 3; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MMP13 PROTEIN, HUMAN; MMP8 PROTEIN, HUMAN; NEUTROPHIL COLLAGENASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETRIC TEST; PERIODONTAL DISEASE; PERIODONTITIS; PRIORITY JOURNAL; TOOTH; ANALYSIS; BLOOD; BODY MASS; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; ENZYMOLOGY; GINGIVA BLEEDING; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PERIODONTAL POCKET; SMOKING; TIME;

BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; GINGIVITIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; SMOKING; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRIGLYCERIDES;

EID: 77953196153     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01659.x     Document Type: Article

References (39)

1. Ainamo J, Lahtinen A, Uitto V (1990). Rapid periodontal destruction in adult humans with poorly controlled diabetes. A report of 2 cases. J Clin Periodontol 17 : 22-28.
2. American Diabetes Association (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (Suppl. 1 S42-S47.
3. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4 : 1-6.
4. Arrieta-Blanco JJ, Bartolome-Villar B, Jimenez-Martinez E, Saaverda-Vallejo P, Arrieta-Blanco FJ (2003). Dental problems in patients with diabetes mellitus (II): gingival index and periodontal disease. Medicina Oral 8 : 233-247.
5. Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ (1982). Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). JADA 104 : 653-660.
6. Collin HL, Uusitupa M, Niskanen L et al (1998). Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 69 : 962-966.
7. Dollery CM, McEwan JR, Henney AM (1995). Matrix metalloproteinases and cardiovascular disease. Circ Res 77 : 863-868.
8. Emrich LJ, Schlossman M, Genco RJ (1991). Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol 62 : 123-131.
9. Fuller K, Chambers TJ (1995). Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 108 : 2221-2230.
10. Gerich JE (2003). Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78 : 447-456.
11. Gümüş P, Buduneli N, Çetinkalp Ş et al (2009). Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study. J Periodontol 80 : 1440-1446.
12. Hanemaaijer R, Sorsa T, Konttinen YT et al (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-a and doxycycline. J Biol Chem 272 : 31504-31509.
13. Hannas AR, Pereira JC, Granjeşro JM, Tjaderhane L (2007). The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65 : 1-13.
14. Hernandez M, Valenzuela MA, Lopez-Otin C et al (2006). Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 77 : 1863-1870.
15. Iacopino AM (2001). Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 6 : 125-137.
16. Ingman T, Tervahartiala T, Ding Y et al (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23 : 1127-1132.
17. 2, IL-1ß, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin Biochem 41 : 863-868.
18. Kardeşler L, Buduneli N, Çetinkalp Ş, Kinane DF (2010). Adipokines and inflammatory mediators following initial periodontal treatment in type 2 diabetic chronic periodontitis patients. J Periodontol 81 : 24-33. DOI: 10.1902/jop.2009.090267
19. Kiili M, Cox SW, Chen HY et al (2002). Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 29 : 224-232.
20. Lauhio A, Salo T, Ding Y et al (1994). In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol 98 : 21-28.
21. Lim LP, Tay FBK, Sum CF, Thai AC (2007). Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 34 : 118-123.
22. Löe H (1993). The sixth complication of diabetes mellitus. Diabetes Care 16 : 476-480.
23. Lu HK, Yang PC (2004). Cross-sectional analysis of different variables of patients with non-insulin dependent diabetes and their periodontal status. Int J Periodontics Rest Dent 24 : 71-79.
24. Marhoffer W, Stein M, Maeser E, Federlin K (1992). Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 15 : 256-260.
25. Mealey BL, Oates TW (2006). Diabetes mellitus and periodontal diseases. AAP-Commissioned review. J Periodontol 77 : 1289-1303.
26. Moreno PR, Murcia AM, Palacios IF (2000). Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 102 : 2180-2184.
27. Persson RE, Hollender LG, MacEntee MI, Wyatt CC, Kiyak HA, Persson GR (2003). Assessment of periodontal conditions and systemic disease in older subjects. J Clin Periodontol 30 : 207-213.
28. Ryan ME, Oana C, Kamer A (2003). The influence of diabetes on the periodontal tissues. JADA 134 : 34S-40S.
29. Safkan-Seppala B, Ainamo J (1992). Periodontal conditions in insulin-dependent diabetes mellitus. J Clin Periodontol 19 : 24-29.
30. Seppala B, Ainamo J (1994). A site by site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol 21 : 161-165.
31. Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10 : 311-318.
32. Taylor G, Burt B, Becker M et al (1998). Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 69 : 76-83.
33. Tervahartiala T, Pirila E, Ceponis A et al (2000). The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 79 : 1969-1977.
34. Tervonen T, Knuuttila M (1986). Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Surg Oral Med Oral Pathol 61 : 346-349.
35. Ünal T, Firatli E, Sivas A, Meriç H, Öz H (1993). Fructosamine as a possible monitoring parameter in non-insulin dependent diabetes mellitus patients with periodontal disease. J Periodontol 64 : 191-194.
36. Verma S, Bhat KM (2004). Diabetes mellitus-a modifier of periodontal disease expression. J Int Academy Periodontol 6 : 13-20.
37. Vlassara H (1992). Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41 (Suppl. 2 52-56.
38. Wahlgren J, Maisi P, Sorsa T et al (2001). Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol 194 : 217-224.
39. Wilson R, Reeves W (1986). Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin ExpImmunol 63 : 478-484.